Interesting facts
Exploring (2R,3R)-2,3-dihydroxybutanedioic acid and 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
This compound combination is a fascinating example of how structural variations in chemical compounds can yield diverse properties and biological activities. Here are some interesting facts:
- Two-Part Synergy: The compound consists of two distinct parts: (2R,3R)-2,3-dihydroxybutanedioic acid, commonly known as tartaric acid, and 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol, which is an important derivative involved in neurotransmitter functions.
- Biological Significance: Tartaric acid plays a crucial role in the winemaking process, affecting the taste and stability of wines. Its presence is essential in forming the characteristic flavor profiles of various wines.
- Pharmaceutical Potential: The second component, characterized by the amino group, indicates potential applications in pharmaceuticals, particularly in creating drugs that influence neurological functions. Compounds like these are often explored for their role as neurotransmitter modulators.
- Natural Sources: Tartaric acid can be naturally isolated from many plants, particularly grapes, and is used as a stabilizing agent in various food products. Interestingly, its optical activity makes it a subject of interest in stereochemistry studies.
- Synergistic Applications: The combination of these two compounds hints at applications in drug formulation, food science, and possibly even in the development of agricultural products with enhanced nutrient profiles.
This compound illustrates the incredible versatility and interdependence of chemical structures in both natural and synthetic applications, making it a great topic for further scientific inquiry and innovation.
Synonyms
Epinephrine bitartrate
51-42-3
l-Adrenaline bitartrate
Bronitin
Epinephrine acid tartrate
Adrenaline acid tartrate
Adrenaline bitartrate
Bronitin Mist
adrenaline tartrate
l-Epinephrine bitartrate
EPINEPHRINE TARTRATE
L-Adrenaline tartrate
l-Epinephrine tartrate
Epinephrine d-bitartrate
(-)-Adrenaline tartrate
l-Adrenaline d-bitartrate
l-Epinephrine d-bitartrate
(-)-Adrenaline bitartrate
Adrenaline hydrogen tartrate
Adrenaline acid tartrate, l-
l-Adrenaline hydrogen tartrate
(-)-Adrenaline hydrogen tartrate
(R)-(-)-Epinephrine bitartrate
L-Epinephrine (Bitartrate)
EINECS 200-097-1
UNII-30Q7KI53AK
Adrenaline bitartate
30Q7KI53AK
DTXSID3049415
Adrenaline (as tartrate)
(-)-Epinephrine bitartrate
D02149
(-)-Adrenaline acid tartrate
(2R,3R)-2,3-dihydroxybutanedioic acid;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
L-epinephrine hydrogen tartrate
1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (R)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt)
16536-89-3
DTXCID2029375
Epinephrine bitartrate [USP:JAN]
Epinephrine bitartrate (Adrenalinium)
(R)-4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol (2R,3R)-2,3-dihydroxysuccinate
NSC 756755
Adrenalinetartrate
1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (theta)-, (theta-(theta,theta))-2,3-dihydroxybutanedioate (1:1) (salt)
LIGNOSPAN FORTE COMPONENT EPINEPHRINE BITARTRATE
Adrenalin tartrate
Asthmahaler
Epinephrine bitartrate (USP:JAN)
Bronkaid Mist Suspension
Primatene Mist Suspension
NSC-756755
24351-82-4
Adrenaline tatrate
EPINEPHRINE BITARTRATE (USP-RS)
EPINEPHRINE BITARTRATE [USP-RS]
ADRENALINE ACID TARTRATE (MART.)
ADRENALINE ACID TARTRATE [MART.]
ADRENALINE TARTRATE (EP MONOGRAPH)
ADRENALINE TARTRATE [EP MONOGRAPH]
EPINEPHRINE BITARTRATE (USP MONOGRAPH)
EPINEPHRINE BITARTRATE [USP MONOGRAPH]
(-)-Epinephrine (+)-bitartrate
L-Epinephrine D-hydrogentartrate
Asmatane mist (TN)
Medihaler-epi (TN)
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol (+)-tartrate (1:1) salt
SCHEMBL40741
(2R,3R)-2,3-dihydroxybutanedioic acid; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
CHEMBL1200818
HY-B0447A
(-)-Epinephrine-(+)-bitartrate
CHEBI:228805
YLXIPWWIOISBDD-NDAAPVSOSA-N
Epinephrine bitartrate (JAN/USP)
HMS3884F06
ADRENALIN TARTRATE [WHO-IP]
EPINEPHRINE BITARTRATE [JAN]
Tox21_202839
s2521
EPINEPHRINE BITARTRATE [VANDF]
EPINEPHRINE D-BITARTRATE [MI]
AKOS015951390
BCP9000650
CCG-267841
EPINEPHRINE BITARTRATE [WHO-DD]
Benzyl alcohol, 3,4-dihydroxy-alpha-((methylamino)methyl)-, (-)-, tartrate (1:1), (+)-
CAS-51-42-3
NCGC00260385-01
BCP0726000242
Adrenaline Tartrate (L-Adrenaline Tartrate)
EPINEPHRINE BITARTRATE [ORANGE BOOK]
(-)-Epinephrine (+)-bitartrate salt, solid
SW219274-2
EPINEPHRINE HYDROGEN TARTRATE [WHO-IP]
D88223
EN300-12578730
EPINEPHRINI HYDROGENOTARTRAS [WHO-IP LATIN]
Q27255971
EPINEPHRINE BITARTRATE COMPONENT OF LIGNOSPAN FORTE
(-)-Epinephrine (+)-bitartrate salt, tested according to Ph.Eur.
Adrenaline tartrate, European Pharmacopoeia (EP) Reference Standard
Adrenaline acid tartrate, British Pharmacopoeia (BP) Reference Standard
Epinephrine bitartrate, United States Pharmacopeia (USP) Reference Standard
Adrenaline tartrate with impurity A, European Pharmacopoeia (EP) Reference Standard
Epinephrine Bitartrate, Pharmaceutical Secondary Standard; Certified Reference Material
(-)-3,4-DIHYDROXY-.ALPHA.-((METHYLAMINO)METHYL)BENZYL ALCOHOL (+)-TARTRATE (1:1) SALT.
200-097-1
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol (2R,3R)-2,3-dihydroxybutanedioate (1:1)
Solubility of (2R,3R)-2,3-dihydroxybutanedioic acid and 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
The solubility of the compounds (2R,3R)-2,3-dihydroxybutanedioic acid (C4H6O6) and 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol (C9H13NO3) can be understood through several key factors:
Specifically, one might expect:
In conclusion, the solubility of these compounds likely reflects their structural characteristics, which favor interactions with polar solvents and enhance their overall dissolvability.